A study by Buterra demonstrated the involvement of CD147 in the intestinal fibrosis process and the ability of AC-73 (a small molecule able to inhibit CD147 signaling and induce autophagy) administration to inhibit the fibrogenic process in TNBS chronic colitis. The gene discussed is BSG; the disease is Chronic colitis.